{"id":"https://openalex.org/W1998129010","doi":"https://doi.org/10.1097/00005344-198804000-00013","title":"Pharmacokinetics and Thrombolytic Properties of a Nonglycosylated Mutant of Human Tissue-Type Plasminogen Activator, Lacking the Finger and Growth Factor Domains, in Dogs with Copper Coil-Induced Coronary Artery Thrombosis","display_name":"Pharmacokinetics and Thrombolytic Properties of a Nonglycosylated Mutant of Human Tissue-Type Plasminogen Activator, Lacking the Finger and Growth Factor Domains, in Dogs with Copper Coil-Induced Coronary Artery Thrombosis","alternate_titles":[],"publication_year":1988,"publication_date":"1988-04-01","ids":{"openalex":"https://openalex.org/W1998129010","doi":"https://doi.org/10.1097/00005344-198804000-00013","mag":"1998129010","pmid":"https://pubmed.ncbi.nlm.nih.gov/2453751"},"language":"en","primary_location":{"id":"doi:10.1097/00005344-198804000-00013","doi":"https://doi.org/10.1097/00005344-198804000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198804000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1998129010"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108438988","display_name":"Patrick A. Cambier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Cambier","raw_affiliation_strings":["Laboratory of Experimental Cardiology, K.U. Leuven; Belgium","*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory of Experimental Cardiology, K.U. Leuven; Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070495078","display_name":"Frans Van de Werf","orcid":"https://orcid.org/0000-0001-9479-7767","observed_orcids":["https://orcid.org/0000-0001-9479-7767"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Van de Werf","raw_affiliation_strings":["Genetics Institute, Boston, Massachusetts, U.S.A","*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics Institute, Boston, Massachusetts, U.S.A","institution_ids":[]},{"raw_affiliation_string":"*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103359776","display_name":"Glenn R. Larsen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. R. Larsen","raw_affiliation_strings":["Genetics Institute, Boston, Massachusetts, U.S.A","*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics Institute, Boston, Massachusetts, U.S.A","institution_ids":[]},{"raw_affiliation_string":"*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023982501","display_name":"D\u00e9sir\u00e9 Collen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"D. Collen","raw_affiliation_strings":["Genetics Institute, Boston, Massachusetts, U.S.A","*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genetics Institute, Boston, Massachusetts, U.S.A","institution_ids":[]},{"raw_affiliation_string":"*Laboratory of Experimental Cardiology, K.U. Leuven; Genetics Institute, Boston, Massachusetts, U.S.A.; Received May 6, 1987; revision accepted July 1, 1987","institution_ids":["https://openalex.org/I99464096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5023982501"],"corresponding_institution_ids":["https://openalex.org/I99464096"],"apc_list":null,"apc_paid":null,"fwci":5.9499,"has_fulltext":false,"cited_by_count":39,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96493929,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":93},"biblio":{"volume":"11","issue":"4","first_page":"468","last_page":"472"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.5503000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10881","display_name":"Blood Coagulation and Thrombosis Mechanisms","score":0.5503000020980835,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10292","display_name":"Acute Myocardial Infarction Research","score":0.4147999882698059,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tissue-plasminogen-activator","display_name":"tissue plasminogen activator","score":0.9959999918937683},{"id":"https://openalex.org/keywords/thrombolytic-efficacy","display_name":"thrombolytic efficacy","score":0.7490000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.8619999885559082},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.8379999995231628},{"id":"https://openalex.org/keywords/fibrinogen","display_name":"fibrinogen","score":0.7139999866485596},{"id":"https://openalex.org/keywords/myocardial-reperfusion","display_name":"myocardial reperfusion","score":0.8149999976158142},{"id":"https://openalex.org/keywords/dogs","display_name":"dogs","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2779679481","wikidata":"https://www.wikidata.org/wiki/Q13581432","display_name":"Plasminogen activator","level":2,"score":0.7602455019950867},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6700196266174316},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.5151840448379517},{"id":"https://openalex.org/C2776572282","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"Tissue plasminogen activator","level":2,"score":0.5099190473556519},{"id":"https://openalex.org/C2779036427","wikidata":"https://www.wikidata.org/wiki/Q381899","display_name":"Fibrinogen","level":2,"score":0.49135151505470276},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4750904142856598},{"id":"https://openalex.org/C2776820930","wikidata":"https://www.wikidata.org/wiki/Q9655","display_name":"Artery","level":2,"score":0.46004465222358704},{"id":"https://openalex.org/C2909373784","wikidata":"https://www.wikidata.org/wiki/Q416351","display_name":"T-plasminogen activator","level":3,"score":0.4411914348602295},{"id":"https://openalex.org/C2776894844","wikidata":"https://www.wikidata.org/wiki/Q1197437","display_name":"Fissipedia","level":2,"score":0.4253280758857727},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41112473607063293},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.34096357226371765},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33957070112228394}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003300","descriptor_name":"Copper","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003327","descriptor_name":"Coronary Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003328","descriptor_name":"Coronary Thrombosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003328","descriptor_name":"Coronary Thrombosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D004285","descriptor_name":"Dogs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005343","descriptor_name":"Fibrinolytic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006031","descriptor_name":"Glycosylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D010959","descriptor_name":"Tissue Plasminogen Activator","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00005344-198804000-00013","doi":"https://doi.org/10.1097/00005344-198804000-00013","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00005344-198804000-00013","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:2453751","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2453751","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2520658626","https://openalex.org/W2068049008","https://openalex.org/W2379898530","https://openalex.org/W1597304804","https://openalex.org/W1985548346","https://openalex.org/W2462075820","https://openalex.org/W2400723122","https://openalex.org/W1971481361","https://openalex.org/W4235107156","https://openalex.org/W2415043583"],"abstract_inverted_index":{"The":[0],"pharmacokinetics":[1],"and":[2,24,30,90,108,164,208,223],"thrombolytic":[3,251],"properties":[4],"of":[5,8,18,32,52,68,72,82,103,117,124,141,148,159,175,182,189],"a":[6,48,146,186,234,246,249],"variant":[7,230],"human":[9],"tissue-type":[10],"plasminogen":[11],"activator":[12],"(t-PA),":[13],"obtained":[14],"by":[15,39],"deletion":[16],"mutagenesis":[17],"the":[19,33,53,190,215,229],"NH2-terminal":[20],"fibronectin-like":[21],"finger":[22],"(F)":[23],"epidermal":[25],"growth":[26],"factor":[27],"(E)":[28],"domains,":[29],"substitution":[31],"three":[34,69],"known":[35],"glycosylated":[36],"Asn":[37],"residues":[38],"Gln":[40],"(t-PA-delta":[41],"FE3X),":[42],"were":[43,61,113,198,218],"studied":[44],"in":[45,76,80,151,155,173],"dogs":[46,153,177],"with":[47],"copper":[49],"coil-induced":[50],"thrombosis":[51],"left":[54],"anterior":[55],"descending":[56],"coronary":[57,133,167],"artery.":[58],"Bolus":[59],"injections":[60,184],"given":[62],"during":[63],"2":[64],"min":[65,112],"to":[66],"groups":[67],"dogs.":[70],"Injection":[71],"0.15":[73],"mg/kg":[74,119,150],"resulted":[75,154],"peak":[77,122,157],"antigen":[78],"levels":[79,123,158],"plasma":[81,121,156,209,237],"1.58":[83],"+/-":[84,88,95,105,110,126,161],"0.72":[85],"micrograms/ml":[86,107,128,163],"(mean":[87],"SEM)":[89],"caused":[91,165,185],"reperfusion":[92,169],"within":[93,135,170],"14":[94],"6":[96],"min.":[97],"With":[98],"0.075":[99],"mg/kg,":[100],"corresponding":[101,216],"values":[102,217],"0.81":[104],"0.20":[106,127],"31":[109,179],"15":[111],"obtained.":[114],"A":[115,138],"bolus":[116,139,247],"0.038":[118],"yielded":[120],"0.43":[125],"but":[129],"did":[130],"not":[131],"cause":[132],"recanalization":[134],"3":[136,171,219],"h.":[137],"injection":[140],"natural":[142],"t-PA":[143],"(Mel-t-PA)":[144],"at":[145],"dose":[147],"0.1":[149],"four":[152,176],"0.46":[160],"0.09":[162],"partial":[166],"artery":[168],"h":[172],"one":[174],"(after":[178],"min).":[180],"None":[181],"these":[183],"significant":[187],"decrease":[188],"fibrinogen":[191],"level.":[192],"Pharmacokinetic":[193],"parameters":[194],"for":[195],"t-PA-delta":[196,231],"FE3X":[197,232],"alpha":[199],"half-life":[200],"(t1/2)":[201],"14-18":[202],"min,":[203,207,220,222],"beta":[204],"t1/2":[205,238],"72-125":[206],"clearance":[210],"21-36":[211],"ml/min.":[212,225],"For":[213],"Mel-t-PA,":[214],"8":[221],"520":[224],"We":[226],"conclude":[227],"that":[228],"has":[233],"markedly":[235],"longer":[236],"than":[239],"does":[240],"Mel-t-PA":[241],"and,":[242],"when":[243],"administered":[244],"as":[245],"injection,":[248],"higher":[250],"efficacy.":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1998129010","counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
